Immune parameter | Congenital heart disease (no, n=13; yes, n=44) | Palatopharyngeal (no, n=45; yes, n=12) | Hypoparathyroidism (no, n=35; yes, n=19) |
Abs CD3 | No: 1276 (951–2060) | No: 1310 (902–1876) | No: 1430 (1220–2020) |
Yes: 1320 (836–1825) | Yes: 1285 (773–2015) | Yes: 820 (600–1410)* | |
RR: 1.2 (0.6 to 2.4) | RR: 0.9 (0.5 to 1.7) | RR: 0.5 (0.3 to 0.9)† | |
Abs CD4 | No: 663 (521–1463) | No: 709 (550–1082) | No: 1007 (556–1566) |
Yes: 860 (551–1166) | Yes: 871 (578–1657) | Yes: 512 (428–860)* | |
RR: 1.4 (0.6 to 3.9) | RR: 1.7 (0.8 to 3.8) | RR: 0.3 (0.1 to 0.7)† | |
Abs CD8 | No: 435 (304–743) | No: 517 (288–686) | No: 675 (456–813) |
Yes: 463 (289–678) | Yes: 400 (318–752) | Yes: 290 (217–550)* | |
RR: 1.7 (0.7 to 4.6) | RR: 1.0 (0.5 to 2.2) | RR: 0.3 (0.1 to 0.7)† | |
Abs CD19 | No: 824 (495 – 1,351) | No: 673 (456–1043) | No: 675 (456–870) |
Yes: 680 (412–1000) | Yes: 680 (449–950) | Yes: 980 (462–1987)* | |
RR: 1.0 (0.4 to 2.7) | RR: 0.9 (0.4 to 1.9) | RR: 2.6 (1.0 to 7.0)† | |
Abs CD56 | No: 397 (354–440) | No: 354 (215–608) | No: 378 (243–608) |
Yes: 348 (236–612) | Yes: 378 (284–860) | Yes: 263 (213–782) | |
RR: 1.0 (0.1 to 7.7) | RR: 1.2 (0.5 to 3.6) | RR: 0.9 (0.3 to 2.7) | |
PHA | No: 31814 (23520–42456) | No: 29167 (23651–52449) | No: 33245 (28808–46492) |
Yes: 28802 (20377–39868) | Yes: 33245 (19335–45747) | Yes: 24186 (6882–33419)* | |
RR: 1.0 (0.4 to 2.2) | RR: 1.0 (0.5 to 2.0) | RR: 0.4 (0.2 to 0.7)† | |
Age at test (months) | No: 10 (5–24) | No: 14 (5–45) | No: 15 (9–51) |
Yes: 15 (5–45) | Yes: 17 (8–24) | Yes: 10 (3–27) |
Absolute (Abs) cell count is given as cells (×106/l); PHA mitogen response is given as cpm. Values for ‘Yes’ and ‘No’ are median (interquartile range),
↵* p<0.05 by Mann–Whitney U test. Values for RR are relative risk (95% CI),
↵† p<0.05 for multivariate Cox regression analysis with control (no infections) as reference group and ‘age of test’ as covariant.